Results 21 to 30 of about 335,951 (265)
Molecules, 2015 This work investigated the spectrum-effect relationships between high performance liquid chromatography (HPLC) fingerprints and the anti-benign prostatic hyperplasia activities of aqueous extracts from Saxifraga stolonifera.
Xing-Dong Wu +8 more
doaj +1 more source
Silodosin in the treatment of benign prostatic hyperplasia. [PDF]
, 2010 Benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) are highly prevalent in older men. Medical therapy is the first-line treatment for LUTS due to BPH.
Rossi, Maxime +5 more
core +1 more source
Journal of Pathology of Nepal, 2011 Background: To treat symptomatic benign prostatic hyperplasia α1-adrenoceptor antagonists with little antagonism at α1b-adrenoceptor were used to avoid orthostatic hypotension.
B Acharya +5 more
doaj +1 more source
The band electrode: Ongoing experience with a novel turp loop to improve hemostasis in 265 patients [PDF]
, 2004 Introduction: Intraoperative bleeding, one of the major complications of conventional transurethral resection of the prostate ( TURP), has led to a search for various alternative methods of tissue ablation in patients with benign prostatic hyperplasia ...
Reich, O., Faul, P.
core +1 more source
Benign prostatic hyperplasia: management [PDF]
, 2012 Men with benign prostatic hyperplasia often experience lower urinary tract symptoms, the severity of which will determine treatment — options include lifestyle interventions, medication and ...
Todd, A, Husband, A
core +6 more sources
PLoS ONE, 2022 Testosterone undecanoate is a hormone agent with long-acting potential and is used for testosterone replacement therapy for hypogonadism. This study was designed to investigate application of testosterone undecanoate in maintaining high androgen levels ...
Jinho An, Hyunseok Kong
doaj +1 more source
Portal Hypertension Secondary to Benign Prostatic Hyperplasia
, 2022 Benign prostatic hyperplasia (BPH) obstructs the bladder outlet. Patients with BPH frequently present with lower urinary tract symptoms. However, patients with BPH can present with serious fatal complications unless diagnosed and treated sufficiently. In
Emrullah Söğütdelen +3 more
core +1 more source
Prostate International, 2018 Background: To investigate the effect of asymptomatic inflammatory prostatitis on clinical outcomes of patients undergoing trans urethral resection of prostate due to benign prostatic hyperplasia.
Suleyman Sami Cakir +5 more
doaj +1 more source
Role of gangliosides in prostate pathology [PDF]
Romanian Journal of Infectious Diseases, 2016 Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age ...
Ilinca Nicolae +2 more
doaj +1 more source
Treatment of Benign Prostatic Hyperplasia [PDF]
Techniques in Vascular and Interventional Radiology, 2012 Lower urinary tract symptoms (LUTS) may be a sign of aging rather than a consequence of benign prostatic enlargement (BPE) or benign prostatic obstruction (BPO). Medical or invasive treatments should address the bothersome symptoms and the quality of life of patients.
Luís Campos, Pinheiro +1 more
openaire +2 more sources